• Gastroesophageal Cancers — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
    Sep 28 2026

    Featuring perspectives from Dr Samuel J Klempner and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:

    • Introduction (0:00)
    • First-Line Treatment of Metastatic Gastroesophageal Cancer (1:48)
    • Management of HER2-Positive Gastroesophageal Cancer (25:11)
    • Neoadjuvant Therapy for Gastroesophageal Cancer (45:13)

    Note to listeners: Subsequent to the recording of this symposium, the FDA approved zanidatamab in combination with chemotherapy with and without tislelizumab for HER2-positive gastric, gastroesophageal junction, or esophageal adenocarcinoma based on results from the Phase III HERIZON-GEA-01 trial.

    CME information and select publications

    Mehr anzeigen Weniger anzeigen
    50 Min.
  • For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2026 Annual ONS Congress
    Aug 24 2026

    Featuring perspectives from Ms Caroline Kuhlman, Dr Eileen M O'Reilly, Dr Philip A Philip and Ms Amanda K Wagner, moderated by Dr O'Reilly, including the following topics:

    • Introduction (0:00)
    • Clinical Presentation and Prognosis of Pancreatic Adenocarcinoma (PAD) (3:29)
    • Recent Advances in Up-Front Treatment for Metastatic PAD (15:47)
    • Selection and Sequencing of Therapy for Relapsed/Refractory Metastatic PAD (39:58)
    • Novel Strategies Targeting RAS Mutations in Advanced PAD (48:20)
    • Utility of Tumor Treating Fields in PAD Management (1:13:58)

    CME information and select publications

    Mehr anzeigen Weniger anzeigen
    1 Std. und 29 Min.
  • Gastroesophageal Cancers — Year in Review Series on Relevant New Datasets and Advances
    Aug 20 2026

    Featuring perspectives from Dr David H Ilson and Dr Kohei Shitara, including the following topics:

    • Introduction (0:00)
    • Biomarker Evaluation in Localized and Metastatic Disease (1:49)
    • Role of Immune Checkpoint Inhibitors in the Management of Gastroesophageal Cancers — Dr Ilson (7:37)
    • Other Available Therapeutic Approaches — Dr Shitara (33:22)

    CME information and select publications

    Mehr anzeigen Weniger anzeigen
    1 Std.
  • Gastroesophageal Cancers — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
    Aug 6 2026

    Featuring perspectives from Dr Yelena Y Janjigian, Dr Manish A Shah and Prof Eric Van Cutsem, moderated by Dr Janjigian, including the following topics:

    • Introduction (0:00)
    • HER2-Targeted Approaches in Advanced Gastroesophageal Cancers — Prof Van Cutsem (2:08)
    • Targeting CLDN18.2 in Advanced Gastroesophageal Cancers — Dr Shah (30:54)
    • Available Immunotherapeutic Strategies for Advanced Gastroesophageal Cancers — Dr Janjigian (1:01:39)

    CME information and select publications

    Mehr anzeigen Weniger anzeigen
    1 Std. und 29 Min.
  • Colorectal Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
    Jul 28 2026

    Featuring perspectives from Dr Tanios Bekaii-Saab, Dr Stacey A Cohen and Dr Arvind Dasari, moderated by Dr Bekaii-Saab, including the following topics:

    • Introduction (0:00)
    • Current and Future Role of Immune Checkpoint Inhibition in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Localized and Locally Advanced Colorectal Cancer (CRC) — Dr Cohen (1:45)
    • Clinical Relevance and Practical Utilization of Molecular Residual Disease Analysis in CRC — Dr Dasari (34:08)
    • Recent Advances in Metastatic CRC: Optimizing Immunotherapy and Other Approaches — Dr Bekaii-Saab (1:00:42)

    CME information and select publications

    Mehr anzeigen Weniger anzeigen
    1 Std. und 29 Min.
  • Colorectal Cancer — Fifth Annual National General Medical Oncology Summit
    Jun 22 2026

    Featuring perspectives from Dr Kristen K Ciombor and Dr John Strickler, including the following topics:

    • Introduction (0:00)
    • Current and Future Role of Immune Checkpoint Inhibitors in the Management of Colorectal Cancer (CRC) — Dr Ciombor (3:58)
    • Other Recent Advances in CRC Management — Dr Strickler (32:57)

    CME information and select publications

    Mehr anzeigen Weniger anzeigen
    50 Min.
  • Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper
    Jun 22 2026

    Featuring an interview with Prof Bernd Kasper, including the following topics:

    • Case: A woman in her early 30s develops a progressing desmoid tumor in her abdomen during pregnancy(0:00)
    • Case: A woman in her late 30s with a painful small desmoid tumor in her rectus abdominus undergoes cryoablation (8:04)
    • Case: A woman in her late teens with recurrent desmoid tumors in her right thigh undergoes multiple resections (13:58)
    • Case: A woman in her mid 70s has a desmoid tumor causing erosion in her scapular region (17:19)

    CME information and select publications

    Mehr anzeigen Weniger anzeigen
    24 Min.
  • Gastroesophageal Cancers — Fifth Annual National General Medical Oncology Summit
    Jun 19 2026

    Featuring perspectives from Dr Yelena Y Janjigian and Dr Samuel J Klempner, including the following topics:

    • Introduction (0:00)
    • Role of Anti-PD-1/PD-L1- and CLDN18.2-Directed Antibodies in the Management of Gastroesophageal Cancers — Dr Klempner (5:52)
    • Management of HER2-Positive Gastroesophageal Cancers — Dr Janjigian (28:20)

    CME information and select publications

    Mehr anzeigen Weniger anzeigen
    51 Min.